Asthma is characterized by
airway hyperresponsiveness and allergic
inflammation, detrimentally affecting the patients' quality of life. The development of new drugs for the treatment of
asthma is warranted to alleviate these issues. Recent studies have demonstrated that sirtuin2 (
SIRT2) aggravates asthmatic
inflammation by up-regulation of T-helper type 2 responses and macrophage polarization. However, effects of
SIRT2 on mast cell activation remain obscure. In this study, we investigated the effects of AGK2, an inhibitor for
SIRT2, on mast cell-mediated allergic airway
inflammation. Pre-treatment with AGK2 inhibited degranulation of mast cells by suppressing the FcεRI signaling pathway and intracellular
calcium influx. The expression of pro-inflammatory
cytokines, such as
tumor necrosis factor (TNF)-α,
interleukin (IL)-1β,
IL-4,
IL-5,
IL-6, and
IL-8, was inhibited via regulation of
transcription factors such as NF-κB and NRF2. These effects of AGK2 were verified in passive cutaneous anaphylaxis and
acute lung injury animal models. AGK2 attenuated
Evans blue pigmentation by inhibiting mast cell activation and lung barrier dysfunction by inhibiting inflammatory responses in these animal models. In the
ovalbumin (OVA)-induced allergic airway
inflammation murine model, AGK2 alleviated allergic
asthma symptoms such as lung histological changes (immune cell and mast cell infiltration,
collagen deposition, and α-smooth muscle actin expression) and serum
immunoglobulins (Ig) levels (
IgE, OVA-specific
IgE,
IgG1, and
IgG2a). Moreover, AGK2 reduced the levels of pro-inflammatory
cytokines (TNF-α, IL-1β, IL-4, IL-5, and IL-6) and inflammatory mediators (
myeloperoxidase,
eosinophil peroxidase, and
tumor growth factor-α) in the bronchoalveolar lavage fluid and lung tissues. In addition, the anti-fibrotic effects of AGK2 were verified using lung epithelial cells and TGF-β/Smad reporter stable cells. In conclusion, our findings suggest that
SIRT2 plays a role in mast cell-mediated airway inflammatory disease. Therefore, AGK2 is a good potential candidate for treating allergic
asthma and
lung inflammation.